Invited Commentary on: Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India Beyond R0: Balancing Oncologic Benefit and Surgical Burden in Metastatic GIST
Invited Commentary on: Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India Beyond R0: Balancing Oncologic Benefit and Surgical Burden in Metastatic GIST. // Journal of Gastrointestinal Surgery. – URL: https://www.sciencedirect.com/science/article/pii/S1091255X26003483?dgcid=rss_sd_all
Invited Commentary on: Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India Beyond R0: Balancing Oncologic Benefit and Surgical Burden in Metastatic GIST. Journal of Gastrointestinal Surgery. https://www.sciencedirect.com/science/article/pii/S1091255X26003483?dgcid=rss_sd_all
“Invited Commentary on: Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India Beyond R0: Balancing Oncologic Benefit and Surgical Burden in Metastatic GIST.” Journal of Gastrointestinal Surgery.
@article{article53644,
title = {Invited Commentary on: Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India Beyond R0: Balancing Oncologic Benefit and Surgical Burden in Metastatic GIST},
journal = {Journal of Gastrointestinal Surgery},
url = {https://www.sciencedirect.com/science/article/pii/S1091255X26003483?dgcid=rss_sd_all}
}